Artiva Biotherapeutics CMO Subhashis Banerjee disposes of 429 common shares worth $5,148 under 10b5-1 plan
Reuters2026/08/20 01:01Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
- Artiva Biotherapeutics Chief Medical Officer Subhashis Banerjee sold 429 common shares on Aug. 18 at USD 12.
- The sale followed an option exercise for 429 shares at USD 1.92.
- Directly held common stock ended at 144,963 shares.
- Employee stock options outstanding ended at 79,571.
Disclaimer:
This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Artiva Biotherapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-357383), on August 19, 2026, and is solely responsible for the information contained therein.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Tenedora de Acciones CM to absorb EMPEI in share-swap merger
Reuters•2026/08/20 02:48
Singapore Dollar Edges Lower as Traders Weigh Treasury Dept's Buyback Announcement -- Market Talk
Dow Jones•2026/08/20 02:44
Sherritt says court declines Kyma bid to force shareholder meeting by end-September 2026
Reuters•2026/08/20 02:36
